Stephen Wargacki serves as Executive at Aquestive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Stephen Wargacki has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 10, 2024 involved receiving (via award) 10,000 shares valued at $0.
Stephen Wargacki currently holds 267,963 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Wargacki has been a net neutral trader of AQST stock. They have purchased $0 and sold $0 worth of shares.
Stephen Wargacki's most recent insider trade was on May 10, 2024, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.88 |
| Discretionary |
| Mar 9, 2024 | AQST | $55.0K | Payment | 11,269 | $4.88 | Discretionary |
| Mar 7, 2024 | AQST | $0 | Award | 112,500 | $N/A | Discretionary |
| Mar 10, 2023 | AQST | $1.6K | Payment | 1,981 | $0.79 | Discretionary |
| Mar 9, 2023 | AQST | $0 | Award | 135,000 | $N/A | Discretionary |